Newsroom Stories

Longtime St. Louis benefactor Joanne Knight has committed up to $11.5 million to Washington University School of Medicine in St. Louis to support an innovative clinical trial aimed at preventing Alzheimer’s disease by treating people before the first signs of the illness appear in the brain.

Researchers at Washington University School of Medicine are conducting an Alzheimer’s prevention trial with young adults from high-risk families to evaluate whether an investigational drug can clear a key Alzheimer’s protein, amyloid beta, and slow or stop the disease.

Scientists at Washington University in St. Louis described for the first time the structure of a bifunctional protein, called CcsBA, that transports heme and attaches it to cytochromes. The study led by Robert Kranz, professor of biology in Arts & Sciences, captured two conformational states of CcsBA, a bacterial and chloroplast protein, allowing researchers to characterize the enzyme mechanism.

A collaboration between Washington University in St. Louis, Université de Montréal and McGill University discovers a new importance of biomolecular condensates.

Amy B. Kweskin, vice chancellor for finance and chief financial officer, has been promoted to executive vice chancellor for finance and will continue as chief financial officer, announced Chancellor Andrew D. Martin. The appointment is effective Jan. 1.

Research from the lab of Kimberly Parker at the McKelvey School of Engineering looks at the interactions of different herbicides and what they mean for herbicide drift.

In April 2008, an oak that had guided travelers for nearly three centuries collapsed. Today, its spirit endures on the Washington University campus, maintaining an ancient practice of human connection with nature.

Anastasia White never forgot the thrill of seeing her designs on stage at the Edison Theatre, or the lessons learned studying fashion at the Sam Fox School of Design & Visual Arts. Today, her company, crescent bleu, creates sustainable swimwear.

Researchers at the School of Medicine were awarded $575.8 million in funding from the National Institutes of Health (NIH) in federal fiscal year 2021, according to the School of Medicine’s 2021 State of the School Report. This is an all-time high for the school.

New Olin Business School research suggests strategies for how nonprofits can handle the issue of costly, unwanted donations while minimizing the risk of donor backlash.